Cempra (CEMP) Gains Ahead of Solithromycin PDUFA Dates
Tweet Send to a Friend
Cempra (NASDAQ: CEMP) is gaining 3.4% in pre-open trade Wednesday ahead of the PDUFA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
